GEORGE F TIDMARSH

CIK 1287235 · President, CEO & Secretary · last filed 2025-02-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2

Companies

4

Total Filings

54

Lifetime Open-Market Net

$961.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
REVBW Director 268 $0.01 $2 $389.1K 12 2025-02-13
Odonate Therapeutics, Inc. (ODT) Delisted Director 77,331 $1.12 $86.6K $0 3 2019-09-23
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted President, CEO & Secretary 1,285,895 $6.22 $8.00M $552.2K 35 2019-04-17
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted CSO and Head of R&D Operations 40,000 $1.03 $41.2K $20.1K 3 2011-01-03

Recent Filings · Page 6 of 6

54 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-02-10 Other (J) +8,000 $10.0K
2011-01-03 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +20,000 $0 EDGAR
2010-08-16 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Buy (P) +5,000 $20.1K EDGAR
2010-07-19 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +15,000 $0 EDGAR
Showing 5154 of 54
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.